Investment firm increases stake in CBD company
Industrial Hemp NewsMarijuana Laws, Regulations, & Politics July 12, 2019 MJ Shareholders 0
Sol Global, a Toronto-based international cannabis investment firm, has increased its stake in a privately held CBD company.
The firm announced Friday it spent $11.5 million (15 million Canadian dollars) in HeavenlyRx. The purchase brings Sol Global to a 42% stake in HeavenlyRx.
The announcement comes less than a week after Sol Global raised $37.5 million (50 million Canadian dollars) and announced plans to increase investment in CBD companies.
Earlier this week, HeavenlyRx bought 15 million shares in Jones Soda Co. for $9 million with an eye toward developing CBD-infused beverages with the brand. HeavenlyRx now holds 39% of the Seattle-based beverage manufacturer.
Sol Global trades on the Canadian Securities Exchange under the ticker symbol SOL.
More details on the investment can be found here.
Subscribe to our Newsletter
MJ Shareholders
MJShareholders.com is the largest dedicated financial network and leading corporate communications firm serving the legal cannabis industry. Our network aims to connect public marijuana companies with these focused cannabis audiences across the US and Canada that are critical for growth: Short and long term cannabis investors Active funding sources Mainstream media Business leaders Cannabis consumers
No comments so far.
Be first to leave comment below.